Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
California Nanotechnologies (OTCPK:CANOF) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
California Nanotechnologies Equity-to-Asset Related Terms
California Nanotechnologies Equity-to-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CANOF vs LIN, SHW, ECL: Equity-to-Asset Comparison
For the Specialty Chemicals subindustry, California Nanotechnologies's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
California Nanotechnologies Equity-to-Asset vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, California Nanotechnologies's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where California Nanotechnologies's Equity-to-Asset falls into.
California Nanotechnologies Equity-to-Asset Calculation
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
California Nanotechnologies's Equity to Asset Ratio for the fiscal year that ended in Feb. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
California Nanotechnologies (CANOF) has a Equity-to-Asset of 0.59 as of May. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on California Nanotechnologies and its competitors. According to the industry distribution chart, California Nanotechnologies ranks #818 out of 1615 companies in the Chemicals industry, placing it in the top 50.7%.
Is California Nanotechnologies' Equity-to-Asset too high?
California Nanotechnologies' current Equity-to-Asset is 0.59. The Chemicals industry median Equity-to-Asset is 0.60. California Nanotechnologies' value of 0.59 is 1.7% below this industry median. Based on the distribution chart, California Nanotechnologies ranks #818 out of 1615 companies in the Chemicals industry, which is below the industry midpoint. Overall, California Nanotechnologies has a GF Score™ of 39/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does California Nanotechnologies' Equity-to-Asset compare to LIN and SHW?
According to the Chemicals industry distribution chart, California Nanotechnologies ranks #818 out of 1615 companies for Equity-to-Asset. This places California Nanotechnologies in the lower half of its industry. The industry median Equity-to-Asset is 0.60. California Nanotechnologies' value of 0.59 is 1.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Chemicals company?
The median Equity-to-Asset among Chemicals companies is 0.60, based on 1,615 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. California Nanotechnologies's current Equity-to-Asset of 0.59 is 1.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on California Nanotechnologies and its competitors. For the Chemicals industry, the median Equity-to-Asset is 0.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. California Nanotechnologies's current Equity-to-Asset is 0.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is California Nanotechnologies stock overvalued right now?
Based on GuruFocus' analysis, California Nanotechnologies (CANOF) is currently considered Fairly Valued. The stock's GF Value™ is $0.22, compared to a current price of $0.22 — trading right at its estimated fair value. The current Equity-to-Asset is 0.59 and 1.7% below the Chemicals industry median of 0.60. California Nanotechnologies' overall GF Score™ is 39/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For California Nanotechnologies (CANOF), the current Equity-to-Asset is 0.59 as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is California Nanotechnologies (CANOF) Overvalued in 2026?
Based on GuruFocus' analysis, California Nanotechnologies stock appears to be undervalued.
The current stock price of $0.22 is trading 0% below its estimated GF Value™ of $0.22.
GuruFocus considers California Nanotechnologies to be Fairly Valued.
Key valuation signals for CANOF:
Equity-to-Asset: 0.59
GF Value™: $0.22 vs. price of $0.22 (0% below fair value)
Industry Position: 1.7% below the Chemicals median (#818 of 1615)
No single metric tells the full story. See the CANOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
California Nanotechnologies Corp engages in the production, and research and development of nanostructured components and materials. Its products include High-Strength Graphite Spark tooling, Plasma Sintering Tooling, Tungsten Carbide Tooling, Carbon Graphite Foil, Carbon Felt and Yarn, and others.
39GF Score
Get the complete analysis for CANOF
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CANOF has been successfully added to your 
